MEDICINE: COMPANY TO POST PROFIT FOR 2011; OUTLOOK FOR 2012 IS GOOD
Santarus Files FDA Application, Buys Drug Rights
Monday, January 9, 2012
Santarus is adding the cholesterol drug Fenoglide to its portfolio of two prescription products, Glumetza and Cycloset, both of which are geared to patients with type 2 diabetes.
While many San Diego companies were taking it slow in the weeks leading up to 2012, Carmel Valley-based biopharmaceutical firm Santarus Inc...
Take 1 minute to subscribe and you'll get this story immediately, plus:
Already a subscriber? Sign in
- 52 weekly issues
- Subscriber-only digital content every business day, plus full access to SDBJ.com archives
- Book of Lists — the most comprehensive business resource in San Diego
- San Diego 500 — influential business leaders you need to know